P78536 (ADA17_HUMAN) Homo sapiens (Human)
Disintegrin and metalloproteinase domain-containing protein 17 UniProtKBInterProSTRINGInteractive Modelling
824 aa; Sequence (Fasta) ; (Isoform 2);
3 identical sequences: Homo sapiens: B2RNB2; Pan troglodytes: A0A2J8NM15; Pan paniscus: A0A2R9BL62
It is possible new templates exist for this target since these models were created.
Available Structures
28 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structure of mature human ADAM17/iRhom2 sheddase complex in complex with ADAM17 prodomain |
Heteromer Q6PJF5; | 1×ZN; 1×CA; | ||||
Assess | ||||||
Structure of human ADAM17/iRhom2 sheddase complex |
Heteromer Q6PJF5; | 1×ZN; 1×CA; | ||||
Assess | ||||||
Crystal structure of the TACE-N-TIMP-3 complex |
Heteromer P35625; | 1×ZN; 1×NA; | ||||
Assess | ||||||
Structure of mature human ADAM17/iRhom2 sheddase complex, conformation 2 |
Heteromer Q6PJF5; | 1×CA; | ||||
Assess | ||||||
Structure of mature human ADAM17/iRhom2 sheddase complex, conformation 1 |
Heteromer Q6PJF5; | 1×CA; | ||||
Assess | ||||||
Crystal structure of the PTPN3 PDZ domain bound to the PBM TACE C-terminal peptide |
Heteromer P26045; | 2×NA; | ||||
Assess | ||||||
Crystal structure analysis 0f the TNF-a Coverting Enzyme (TACE) in complexed with Aryl-sulfonamide | monomer | 1×ZN; 1×283; | ||||
Assess | ||||||
Crystal structure of TACE in complex with IK682 | monomer | 1×ZN; 1×541; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with the first hydantoin inhibitor occupying the S1' … | monomer | 1×ZN; 1×724; | ||||
Assess | ||||||
Novel thio-based TACE inhibitors Part 2: Rational design, synthesis and SAR of thiol-contaning aryl… | monomer | 2×ZN; 1×440; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TNF-alpha converting enzyme (TACE) with inhibitor | monomer | 1×ZN; 1×IH6; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor | monomer | 1×ZN; 1×4NH; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with carboxylate inhibitor | monomer | 1×ZN; 1×INN; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with 2-(2-Aminothiazol-4-yl)pyrrolidine-Based Tartrat… | monomer | 1×IPA; 1×INN; 1×ZN; 1×CA; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with hydroxamate inhibitor | monomer | 1×ZN; 1×INN; 1×CIT; | ||||
Assess | ||||||
Crystal structure of the catalytic domain of TACE with Isoindolinone-biphenyl-hydantoin inhibitor | monomer | 1×Z93; 1×ZN; | ||||
Assess | ||||||
Crystal structure of TACE in complex with JMV 390-1 | monomer | 1×ZN; 1×INN; | ||||
Assess | ||||||
Crystal structure of TACE in complex with TAPI-2 | monomer | 1×ZN; 1×CA; 1×INN; 1×IPA; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with tartrate-based inhibitor | monomer | 1×ZN; 1×INN; | ||||
Assess | ||||||
Crystal structure of the catalytic domain of TACE with Indazolinone-phenyl-hydantoin inhibitor | monomer | 1×ZN; 1×727; 1×IPA; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with phenyl-pyrrolidinyl-tartrate inhibitor | monomer | 1×ZN; 1×INN; 1×IPA; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with hydroxamate inhibitor | monomer | 1×ZN; 1×615; 1×INN; | ||||
Assess | ||||||
Crystal structure of catalytic domain of tace with benzimidazolyl-thienyl-tartrate based inhibitor | monomer | 1×ZN; 1×50X; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with hydantoin inhibitor | monomer | 1×ZN; 1×INN; 1×IPA; | ||||
Assess | ||||||
Crystal structure of catalytic domain of TACE with inhibitor | monomer | 1×ZN; 1×INN; | ||||
Assess | ||||||
CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) | monomer | 1×ZN; 1×INN; | ||||
Assess | ||||||
Crystal Structure of TACE with Tryptophan Sulfonamide Derivative Inhibitor | monomer | 1×792; 1×ZN; | ||||
Assess | ||||||
The membran-proximal domain of ADAM17 | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8snl.1.A | monomer | 0.78 | 1×ZN; 1×CA; | 100.00 | ||
Assess |
1 SWISS-MODEL model built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 8snl.1.A | monomer | 0.79 | 1×ZN; 1×CA; | 100.00 | |
Assess |